AMN Healthcare Services, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AMN Healthcare Services, Inc. on May 4, 2026, covering events occurring on May 1, 2026. The filing documents the results of the Company's Annual Meeting of Shareholders held on that date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting outcomes rather than financial performance.
Material Changes and Voting Results
Shareholders voted on five proposals at the Annual Meeting. The outcomes were as follows:
- Election of Directors: All nine nominees were elected, including Jorge A. Caballero, Mark G. Foletta, Teri G. Fontenot, Cary S. Grace, James H. Hinton, Celia P. Huber, Daphne E. Jones, Eric P. Palmer, and Sylvia D. Trent-Adams.
- Executive Compensation: The advisory vote on executive compensation was approved with approximately 22.7 million votes for and 7.1 million against.
- Independent Auditor: The ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was approved.
- Equity Plan Amendment: Amendment No. 1 to the AMN Healthcare 2025 Equity Plan was approved.
- Shareholder Proposal: A shareholder proposal requesting an "Independent Board Chairman" was not approved, receiving approximately 7.5 million votes for and 22.3 million against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, or contingencies. The document serves as a record of the shareholder vote and the approval of the equity plan amendment, with full details referenced in the Definitive Proxy Statement filed on March 18, 2026.
Key Facts for Investor Verification
- Verify the specific terms of Amendment No. 1 to the AMN Healthcare 2025 Equity Plan in the referenced Proxy Statement and Exhibit 10.1.
- Note the significant opposition (approx. 22.3 million votes) to the shareholder proposal for an Independent Board Chairman.
- Confirm the re-election of the full slate of directors, noting the vote counts for each individual.
- Review the Definitive Proxy Statement (filed March 18, 2026) for detailed context on the executive compensation advisory vote.